Clinical Trial Update: Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study [NA]

View source ↗

Summary

This record reports the completion of a clinical trial evaluating a spinal cord neuromodulation therapy (SCONE) by SpineX for neurogenic bladder, including indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neurogenic Bladder
• Spinal Cord Injury
• Stroke

Drugs mentioned

• SCONE (spinal cord neuromodulation device)

Snippet

Sponsor: SpineX Inc. | Conditions: Neurogenic Bladder, Spinal Cord Injuries (Complete and Incomplete) | NA | Status: COMPLETED